Chronic Wound Care Market Report 2026

The chronic wound care market size has grown strongly in recent years. It will grow from $16.42 billion in 2025 to $17.64 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising incidence of chronic wounds, increased prevalence of diabetes-related complications, expansion of hospital wound care programs, growing use of surgical wound management products, improved access to wound care therapies.

The chronic wound care market size is expected to see strong growth in the next few years. It will grow to $22.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing aging population, rising demand for home-based wound care, growing focus on faster wound healing outcomes, expansion of digital wound assessment tools, increasing adoption of advanced therapy devices. Major trends in the forecast period include increasing adoption of advanced wound dressings, rising use of negative pressure wound therapy devices, growing integration of smart wound monitoring solutions, expansion of bioactive and antimicrobial dressings, enhanced focus on personalized wound care.

The rising number of sports injuries is expected to propel the growth of the chronic wound care market in the coming years. Sports injuries refer to physical damage or trauma sustained during participation in sports or recreational activities. The incidence of sports injuries is increasing due to factors such as higher training intensity, insufficient warm-up routines, inadequate protective equipment, and improper techniques. Chronic wound care supports the management of sports-related injuries by promoting faster healing, reducing the risk of infection, and preventing complications, which helps patients return to physical activity more quickly. For instance, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, rugby, including both league and union formats, recorded the highest rate of sports injury-related hospitalizations relative to participation during 2023-24, with approximately 1,400 hospitalizations per 100,000 participants. Therefore, the increasing number of sports injuries is driving the growth of the chronic wound care market.

Major companies operating in the chronic wound care market are increasingly focusing on the development of innovative systems such as negative pressure wound therapy systems to support more comfortable and convenient home-based care. A negative pressure wound therapy system is a medical device that applies controlled suction to a wound to promote healing by removing excess fluid, reducing swelling, and improving blood flow to the affected tissue. For example, in April 2024, Smith & Nephew, a UK-based medical equipment manufacturing company, launched RENASYS EDGE in the United States as a patient-focused solution for chronic wound treatment. The system is designed with a lightweight and compact structure and features an intuitive interface for clinicians. Its user-friendly design offers step-by-step guidance for therapeutic use, while technical support can be accessed with a single click during setup through near-field communication functionality. Smith & Nephew also provides round-the-clock patient support and access to a clinical helpline. These technological enhancements, including improved portability and near-field communication integration, enhance patient comfort and address the increasing demand for effective home-based chronic wound care, while potentially reducing overall healthcare costs.

In May 2023, LifeNet Health, a US-based non-profit organization, acquired the wound care division of Bioventus Inc. for $0.085 billion. This acquisition expanded LifeNet Health’s chronic wound care portfolio with clinically proven products such as TheraSkin, TheraGenesis, and SonicOne, supporting improved patient outcomes and addressing critical healthcare needs. The transaction also strengthened LifeNet Health’s position within the chronic wound care market. Bioventus Inc. is a US-based medical device company specializing in chronic wound care solutions.

Major companies operating in the chronic wound care market are Cardinal Health Inc., Johnson & Johnson, 3M Company, Medtronic PLC, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Essity AB (BSN Medical), Medline Industries Inc., Smith & Nephew PLC, Ethicon Inc., Coloplast AS, B. Braun Holding GmbH & Co. KG, Paul Hartmann AG, ConvaTec Group PLC, Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Acelity L.P. Inc., MTF Biologics, MIMEDX Group Inc., Vericel Corporation, Anika Therapeutics Inc., Oneness Biotech Co. Ltd., Marine Polymer Technologies Inc., Tissue Regenix Group PLC, Alleva Medical Ltd.

North America was the largest region in the chronic wound care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic wound care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chronic wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the chronic wound care market by increasing costs of imported wound dressings, therapy devices, antimicrobial materials, sensors, and medical-grade polymers. Hospitals and homecare providers in North America and Europe are most affected due to dependence on imported advanced wound care products, while Asia-Pacific faces cost pressure on manufacturing consumables. These tariffs are raising treatment costs and slowing product adoption. At the same time, they are encouraging domestic production of wound care consumables, regional supplier expansion, and innovation in cost-efficient wound management solutions.

The chronic wound care market research report is one of a series of new reports that provides chronic wound care market statistics, including chronic wound care industry global market size, regional shares, competitors with a chronic wound care market share, detailed chronic wound care market segments, market trends and opportunities, and any further data you may need to thrive in the chronic wound care industry. This chronic wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chronic wound care involves the specialized medical management and treatment of wounds that do not progress through the normal stages of healing within an expected period and often persist for a prolonged duration. It is used to manage various long-standing wounds with the goal of promoting healing and preventing complications.

The primary types of chronic wound care products include advanced wound dressings, surgical wound care, sutures and staples, tissue adhesives and sealants, anti-infective dressings, traditional wound care products, and wound therapy devices. Advanced wound dressings are specialized materials applied directly to wounds to support healing and reduce the risk of infection, including hydrocolloids, hydrogels, foams, and films. These products are used for multiple applications such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others, across various end users including hospitals, clinics, homecare settings, and others.

The chronic wound care market consists of revenues earned by entities by providing services, such as wound assessment, wound debridement, infection control, wound dressing changes, negative pressure wound therapy, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic wound care market also includes sales of debridement products, moisture control products, and antimicrobial agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.